Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Human Immunology
|
April 26, 2011
Adenosine A2(A) receptor modulates the oxidative stress response of primed polymorphonuclear leukocytes after parabolic flight
Ines Kaufmann, Matthias Feuerecker, Alex Salam, et al.
Plos Neglected Tropical Diseases
|
November 9, 2023
A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings
Josephine Bourner, Lovarivelo Andriamarohasina, Alex Salam, et al.
Emerging Infectious Diseases
|
October 19, 2019
Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
Nzelle Delphine Kayem, Amanda Rojek, Emmanuelle Denis, et al.
Plos One
|
July 30, 2014
Chronic artificial blue-enriched white light is an effective countermeasure to delayed circadian phase and neurobehavioral decrements
Raymond P Najjar, Luzian Wolf, Jacques Taillard, et al.
BMC Medicine
|
September 7, 2019
A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections
Louise Sigfrid, Chelsea Perfect, Amanda Rojek, et al.
The Journal of Infectious Diseases
|
December 12, 2019
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
Yeming Wang, Guohui Fan, Alex Salam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2022
Infectious Proctitis due to Human Mpox
Keerti Gedela, Dayana Da Silva Fontoura, Alex Salam, et al.
Trials
|
August 19, 2020
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
Rindra Vatosoa Randremanana, Mihaja Raberahona, Mamy Jean de Dieu Randria, et al.
Ebiomedicine
|
November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Yeming Wang, Wu Zhong, Alex Salam, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Human Immunology
|
April 26, 2011
Adenosine A2(A) receptor modulates the oxidative stress response of primed polymorphonuclear leukocytes after parabolic flight
Ines Kaufmann, Matthias Feuerecker, Alex Salam, et al.
Plos Neglected Tropical Diseases
|
November 9, 2023
A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings
Josephine Bourner, Lovarivelo Andriamarohasina, Alex Salam, et al.
Emerging Infectious Diseases
|
October 19, 2019
Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
Nzelle Delphine Kayem, Amanda Rojek, Emmanuelle Denis, et al.
Plos One
|
July 30, 2014
Chronic artificial blue-enriched white light is an effective countermeasure to delayed circadian phase and neurobehavioral decrements
Raymond P Najjar, Luzian Wolf, Jacques Taillard, et al.
BMC Medicine
|
September 7, 2019
A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections
Louise Sigfrid, Chelsea Perfect, Amanda Rojek, et al.
The Journal of Infectious Diseases
|
December 12, 2019
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
Yeming Wang, Guohui Fan, Alex Salam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2022
Infectious Proctitis due to Human Mpox
Keerti Gedela, Dayana Da Silva Fontoura, Alex Salam, et al.
Trials
|
August 19, 2020
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
Rindra Vatosoa Randremanana, Mihaja Raberahona, Mamy Jean de Dieu Randria, et al.
Ebiomedicine
|
November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Yeming Wang, Wu Zhong, Alex Salam, et al.
Page
of 1